Wireless oxygen sensor for newborns put to the test
NCT ID NCT07813091
First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time
Summary
Researchers are testing the oxygen-reading part of a new wireless monitoring system called NeWTS. They want to see whether it measures blood oxygen as accurately as a standard wired clinical monitor and a gold-standard blood gas analyser. The study enrolls 24 healthy adults aged 18 to 55, not newborns, as an early step before the device is considered for use in neonatal intensive care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a wireless oxygen monitoring device called the Neonatal Wireless Transmission System
- What this could lead to
- If it works, the device could give newborns in intensive care a wireless way to have their blood oxygen tracked, without the tangle of wires.
- What could go wrong
- This is an early device test in healthy adults, not babies. Readings that look accurate in adults may not hold up in newborns, and the device may not match standard blood tests closely enough to be trusted in the NICU.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
About 24 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2027
An estimate. Start dates often move.
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Be aged 18-55 years * Willing and have capacity to provide written informed consent * Healthy adult volunteers classified as ASA 1 * Non-smoker (this does not exclude vaping) * Willing and able to comply with study procedures and duration Exclusion Criteria: * History of Bleomycin treatment at any time * Smokers or individuals exposed to high levels of carbon monoxide * Compromised circulation, injury, or physical malfunction of the sensor sites which would limit the ability to test sites needed for the study * Morbidly obese (defined as BMI \>39.5) or significantly underweight (BMI \<18) * Pregnancy * Participants who can conceive a pregnancy or carry a child (including women, trans men and non-binary people) will be required to demonstrate a negative pregnancy test * Unwillingness or inability to remove coloured nail polish or nail attachments from test digits (relevant for reference pulse oximeter) or to have medical monitoring attached * Known health conditions or medications disclosed on Health Assessment Form which mean that participant is not healthy * Allergy to lidocaine * Known allergy to adhesives used in medical dressings or tapes or materials used to adhere NeWTS components. * Enrolment in any other clinical investigation/trial that is deemed would compromise the validity of the data or safety of the patient (at the discretion of the local PI) * Sunburn/spray tan or other pigments on hands
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Device performance are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Clinical Research Facility
Birmingham, England, B15 2GW, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.